The present invention in one embodiment provides a compound of Formula I:or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification. The compound of Formula I is useful for the treatment of a disease selected from the group consisting of inflammatory bowel disease (IBD), such as Crohns disease or ulcerative colitis, and celiac disease.
